TY - JOUR T1 - Dreaming during the Covid-19 pandemic: Computational assessment of dream reports reveals mental suffering associated with negative feelings and contagion fear JF - medRxiv DO - 10.1101/2020.05.19.20107078 SP - 2020.05.19.20107078 AU - Natália Bezerra Mota AU - Janaina Weissheimer AU - Marina Ribeiro AU - Mizziara de Paiva AU - Juliana D’Ávilla AU - Gabriela Simabucuru AU - Monica Frias Chaves AU - Lucas Cecchi AU - Jaime Cirne AU - Guillermo Cecchi AU - Cilene Rodrigues AU - Mauro Copelli AU - Sidarta Ribeiro Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/21/2020.05.19.20107078.abstract N2 - Neuroscience and psychology agree that dreaming helps to cope with negative emotions and learn from experience. The current global threat related to the COVID-19 pandemic led to widespread social isolation. How does this situation affect dreams? Is dreaming during the pandemic related to mental suffering? Does the act of observing dreams help to mitigate mental suffering? To address these questions, we applied natural language processing tools to study 210 dream reports (n=67, Pandemic group n=42, plus control group balanced for age, sex and education) either before the Covid-19 outbreak or during March-April, 2020, following the pandemic announcement by the WHO and quarantine was imposed in Brazil. Post-announcement dreams showed a higher proportion of words related to anger and sadness, and higher average semantic similarities to the terms “contamination” and “cleanness”, which tended to increase over time. These features were associated with mental suffering related to social isolation, as they explained 39% of the variance in PANSS negative subscale (p=0.0092). Besides, dream observation was positively self-evaluated and dream similarities to “contamination” and “cleanness” revealed different impacts of the dream observation effect. These results corroborate the hypothesis that pandemic dreams reflect mental suffering, fear of contagion, and important changes in daily habits.Competing Interest StatementDr. NBM owns stock in the company Psychomeasure and works as CSO of the same company. The remaining authors declare no potential conflict of interest.Funding StatementWe want to thanks the financial support from Boehringer-Ingelheim (grants 270,906 and 270,561).Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) PVE grant 401518/2014-0, Universal grants 480053/2013-8 and 408145/2016-1, and Research Productivity grants 308775/2015-5, 306659/2019-0 and 310712/2014-9; CoordenaÇão de AperfeiÇoamento de Pessoal de Nível Superior (CAPES) Projects OBEDUC-ACERTA 0898/2013 and STIC AmSud 062/2015; FundaÇão de Amparo à Ciência e Tecnologia do Estado de Pernambuco (FACEPE); Center for Neuromathematics of the São Paulo Research Foundation FAPESP (grant 2013/07699-0); and the Austrian Science Fund Project (FWF) Y00777.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are available under request. ER -